市场调查报告书
商品编码
1297125
可吸收鼻腔植入物设备市场 - 按产品类型(药物洗脱可吸收鼻腔植入物、非药物洗脱鼻腔植入物)、按材料类型(聚合物、CMC)、按最终用途(医院、门诊手术中心)及2023-2032年预测Absorbable Nasal Implant Devices Market - By Product Type (Drug Eluting Absorbable Nasal Implants, Non-Drug Eluting Nasal Implants), By Material Type (Polymer, CMC), By End-use (Hospitals, Ambulatory Surgical Centers) & Forecast 2023 - 2032 |
到2032年,全球可吸收鼻腔植入设备市场规模将明显扩大 老年人鼻腔疾病的高发率增加了对可吸收鼻腔植入设备的需求。此外,全球范围内医疗保健支出的增加促进了新型可吸收鼻腔植入设备的发展,补充了行业增长。事实上,在该领域经营的行业领导者正专注于产品创新以超越竞争。越来越多的战略努力将在2023-2032年为可吸收的鼻腔植入设备行业带来值得称赞的收益。
整体市场份额根据产品、材料、最终用途和地区进行分类。
就产品而言,到2032年,非洗脱部分将以显著的复合年增长率增长。这些设备的炎症减少,有利于它们的采用。这些植入物通常由生物相容性材料制成,随着时间的推移会被身体吸收。随着植入物的吸收,它减少了炎症或异物反应的风险。这可以使容易形成过多疤痕组织的病人或那些对异物有不良反应历史的病人受益。
基于材料,羧基甲基纤维素(CMC)部分的市场价值将在2032年之前描绘出可观的增长。这些植入物的多功能性和易用性支持其采用。它们可用于各种鼻部手术,包括鼻中隔整形术、隆鼻术和鼻部创伤重建。它们可以被塑造成适合每个病人的具体解剖要求的形状,使它们在不同的手术应用中具有多样性。
根据最终用途,非住院手术中心(ASCs)部分的可吸收鼻腔植入设备市场将在2032年之前大幅增长。ASCs通常提供一个更个性化和以病人为中心的体验。这些设施的规模较小,可以提供更多的个性化护理和关注。患者可以更直接地接触到他们的手术团队,从而使患者的满意度和舒适度更高。此外,非住院手术中心数量的增加正在为该领域的增长创造有利可图的机会。
从区域角度看,亚太地区可吸收鼻腔植入设备的市场份额将在2023年至2032年之间以显著的复合增长率增长。鼻部疾病的发病率越来越高,加上医疗器械行业的蓬勃发展,为区域增长带来了大量的机会。根据印度IBEF的数据,在22财年,该国医疗设备的出口价值为29.0亿美元,预计到2025年将达到100亿美元。
Global Absorbable Nasal Implant Devices Market size will expand significantly through 2032 High prevalence of nasal disorders in aging people has increased the demand for absorbable nasal implant devices. Moreover, increasing healthcare expenditure across the globe has fostered the development of novel absorbable nasal implant devices, supplementing industry growth. In fact, the industry leaders operating in the space are focusing on product innovations to outshine the competition. Increasing strategic efforts will bring commendable gains to the absorbable nasal implant devices industry over 2023-2032.
The overall market share is classified based on product, material, end-use, and region.
With respect to product, the non-eluting segment will grow at a significant CAGR through 2032. Reduced inflammation with these devices favors their adoption. These implants are typically made from biocompatible materials that are absorbed by the body over time. As the implant absorbs, it reduces the risk of inflammation or foreign body reactions. This can benefit patients prone to excessive scar tissue formation or those with a history of adverse reactions to foreign materials.
Based on material, the market value from the carboxy methyl cellulose (CMC) segment will depict considerable growth through 2032. The versatility and ease of use of these implants support their adoption. These can be used in various nasal procedures, including septoplasty, rhinoplasty, and nasal trauma reconstruction. They can be molded and shaped to fit the specific anatomical requirements of each patient, making them versatile for different surgical applications.
Based on end-use, absorbable nasal implant devices market from the ambulatory surgical centers (ASCs) segment will surge significantly through 2032. ASCs often provide a more personalized and patient-centered experience. The smaller size of these facilities allows for more individualized care and attention. Patients may have more direct access to their surgical team, resulting in higher level of patient satisfaction and comfort. Moreover, the growing number of ambulatory surgical centers is creating lucrative opportunities for segment growth.
From the regional perspective, the Asia Pacific absorbable nasal implant devices market share will grow at a notable CAGR between 2023 and 2032. Growing prevalence of nasal disorders, coupled with the flourishing medical device sector, is generating a plethora of opportunities for regional growth. As per India's IBEF, in FY22, the export of medical devices from the country was worth USD 2.90 billion and is projected to reach USD 10 billion by 2025.